Related Experiment Video

Updated: Aug 7, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

Azithromycin-induced QT prolongation in elderly patient

Vincenzo Russo1, Gianfranco Puzio, Nicola Siniscalchi

  • 1Department of Internal Medicine and Aging Disease, Second University, Naples, Italy. v.p.russo@libero.it

Acta Bio-Medica : Atenei Parmensis
|July 22, 2006
PubMed

Insights

Azithromycin can prolong the QT interval in elderly patients with heart conditions, increasing arrhythmia risk. Discontinuation of this antibiotic led to QT interval normalization in a case study.

Area of Science:

  • Cardiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Idiopathic dilated cardiomyopathy is a significant cardiac condition.
  • Community-acquired pneumonia requires effective antibiotic treatment.
  • Azithromycin is a commonly prescribed macrolide antibiotic.

Observation:

  • An elderly patient with idiopathic dilated cardiomyopathy was treated with azithromycin.
  • The patient developed significant QT interval prolongation after two days of azithromycin therapy.

Findings:

  • Azithromycin treatment was associated with a marked prolongation of the QT interval.
  • QT interval prolongation is a known risk factor for potentially fatal ventricular tachyarrhythmias.
  • Cessation of azithromycin resulted in the normalization of the QT interval within three days.

Implications:

  • Clinicians should exercise caution when prescribing azithromycin to elderly patients with pre-existing cardiac conditions like dilated cardiomyopathy.
  • Monitoring the QT interval is crucial in patients at risk for drug-induced arrhythmias.
  • This case highlights the importance of considering antibiotic-induced cardiac side effects in differential diagnoses.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...